← All trials
NCT04699188
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 24, 2021
- Primary completion
- Aug 21, 2024
- Completion date
- Aug 21, 2024
- First posted
- Jan 7, 2021
- Last posted
- Sep 14, 2021
- Enrollment
- 345
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- NovartisLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.